HomeNewsOpinionMedical crowd-funding and State’s failure to control healthcare costs

Medical crowd-funding and State’s failure to control healthcare costs

Indians are spending around Rs 3.4 lakh crore on healthcare from their savings. This is roughly 4.5 times higher than the budget allocations for the Government of India’s Ministry of Health and Family Welfare in 2021-22

March 18, 2021 / 15:10 IST
Story continues below Advertisement
Vaccination drive is underway in India since January 16. (Image: Reuters)
Vaccination drive is underway in India since January 16. (Image: Reuters)

On February 12 in an Op-Ed in USA Today, the CEO of United States-based crowd-funding website GoFundMe, warned about the overuse of the platform for essential services such as healthcare, education and food. In last few years, medical crowd-funding in India has also witnessed tremendous growth. The medical crowd-funding ecosystem in India may not have grown as much as the one in the US, but its rise here highlights larger State apathy and inaction over rising costs of healthcare.

Estimates show that multiple crowd-funding platforms have raised around ₹272 crore for healthcare. In last five years, all medical crowd-funding activities might have raised Rs 1000 crore. Both Milaap and Ketto have registered a 300 percent and 50 percent growth in terms of number of medical crowd-funding campaigns respectively with thousands for medical crowd-funding campaigns being launched every month.

Story continues below Advertisement

Rising Cost Of Healthcare

While growing digital penetration and retail donation has a significant role to play in the growth of medical crowd-funding in India, the rising costs of healthcare and the largely unregulated prices at private healthcare facilities seem to be prime drivers.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show